hg19 drug

Aliases

GRCh37, human genome hg19, human reference genome hg19, reference human genome hg19

External links

DrugBank · PubChem

No related entities found.

Mentioned in (37)

Papers in which this entity is mentioned.

• Enhancer activation from transposable elements in extrachromosomal DNA. (2025)
• Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States. (2025)
• ChromoGen: Diffusion model predicts single-cell chromatin conformations. (2025)
• Efficient and accurate search in petabase-scale sequence repositories. (2025)
• Massively parallel reporter assay investigates shared genetic variants of eight psychiatric disorders. (2025)
• Variant interpretation using population databases: Lessons from gnomAD. (2022)
• Inferring gene expression from cell-free DNA fragmentation profiles. (2022)
• Integrative reconstruction of cancer genome karyotypes using InfoGenomeR. (2021)
• Accurate detection of circulating tumor DNA using nanopore consensus sequencing. (2021)
• Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. (2020)
• GenMap: ultra-fast computation of genome mappability. (2020)
• Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior. (2020)
• Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks. (2020)
• Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers. (2020)
• AmpliconReconstructor integrates NGS and optical mapping to resolve the complex structures of focal amplifications. (2020)
• Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells. (2019)
• A multi-task convolutional deep neural network for variant calling in single molecule sequencing. (2019)
• Genome-wide cell-free DNA fragmentation in patients with cancer. (2019)
• Best practices for bioinformatic characterization of neoantigens for clinical utility. (2019)
• Complex rearrangements and oncogene amplifications revealed by long-read DNA and RNA sequencing of a breast cancer cell line. (2018)
• Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes. (2018)
• Tumor fraction in cell-free DNA as a biomarker in prostate cancer. (2018)
• The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions. (2018)
• Picky comprehensively detects high-resolution structural variants in nanopore long reads. (2018)
• Nanopore Sequencing Reveals High-Resolution Structural Variation in the Cancer Genome (2017)
• Statistical algorithms improve accuracy of gene fusion detection. (2017)
• Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. (2017)
• Mapping and phasing of structural variation in patient genomes using nanopore sequencing. (2017)
• Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. (2017)
• Fast and Accurate Genomic Analyses using Genome Graphs (2017)
• Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin. (2016)
• DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. (2016)
• Experiences with workflows for automating data-intensive bioinformatics. (2015)
• The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing. (2015)
• Estimating telomere length from whole genome sequence data. (2014)
• Characterizing and measuring bias in sequence data. (2013)
• DELLY: structural variant discovery by integrated paired-end and split-read analysis. (2012)

Merged raw entities (5)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.